-
-
WHO recommendations for antiviral use for H1N1 flu; antibiotic use trends for acute respiratory tract infection; denosumab clears FDA Expert Panel; FDA Actions.
-
Although ischemic left ventricular (LV) dysfunction is an indication for revascularization, little is known about the long-term benefits of revascularization and the value of viability studies.
-
There is considerable concern regarding in-stent thrombosis of drug-eluting stents (DES) when aspirin and clopidogrel are stopped for non-cardiac surgery (NCS), but a paucity of data.
-
The dispatcher-assisted resuscitation trial (DART) tested the hypothesis that 911 dispatcher instructions to provide chest compressions only would be superior to similar instructions that included both chest compressions and rescue breathing.
-
Current guidelines recommend mitral-valve surgery for severe organic mitral regurgitation in asymptomatic patients if exercise pulmonary hypertension (PASP > 60 mmHg) is demonstrated.
-
-
Lorcaserin submitted for FDA review, FDA advisory panel votes against phentermine/topiramate, mixed vote on rosiglitazone, advisory panel votes to remove breast cancer indication from bevacizumab labeling, no increase in seizures found with DTaP vaccine, new REMS for quinine.
-
-
Platelet aggregation is an important pathophysiological step in the development of myocardial infarction (MI), and intensive anti-platelet therapy has become a cornerstone of therapy in patients presenting with MI.
